Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms M Mosca, G Hermange, A Tisserand, R Noble, C Marzac, C Marty, ... Blood 138 (22), 2231-2243, 2021 | 50 | 2021 |
Inferring the initiation and development of myeloproliferative neoplasms G Hermange, A Rakotonirainy, M Bentriou, A Tisserand, M El-Khoury, ... Proceedings of the National Academy of Sciences 119 (37), e2120374119, 2022 | 21 | 2022 |
Optimizing IFN alpha therapy against myeloproliferative neoplasms G Hermange, PH Cournède, I Plo Journal of Pharmacology and Experimental Therapeutics 387 (1), 31-43, 2023 | 5 | 2023 |
Mathematical modelling, selection, and hierarchical inference to determine the minimal dose in IFNα therapy against Myeloproliferative Neoplasms G Hermange, W Vainchenker, I Plo, PH Cournède Mathematical Medicine and Biology: A Journal of the IMA, dqae006, 2024 | 3 | 2024 |
Amplification of Von Willebrand Factor-Positive CALRmut Disease-Initiating Hematopoietic Stem Cells Is Associated to the Activation of the PERK/EiF2a Branch of Unfolded Protein … C Benlabiod, G Hermange, L Borderon, Q Blampey, M Evrard, ... Blood 144, 752, 2024 | | 2024 |
Modélisation mathématique des néoplasmes myéloprolifératifs: de leur développement à leur traitement par Interféron alpha G Hermange université Paris-Saclay, 2023 | | 2023 |
Modélisation mathématique de l'hématopoïèse et des hémopathies: développement, dynamique et traitement G Hermange, PH Cournède, I Plo Hématologie 28 (4), 183-200, 2022 | | 2022 |